SCHEMBL3222938

SCHEMBL3222938

Cc1ccc(S(=O)(=O)N2CCC(Oc3ccccc3C(F)(F)F)CC2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.63
KMT2A Q03164 2/20 0.63
ALDH1A1 P00352 4/20 0.56
CYP3A4 P08684 1/20 0.56
GAA P10253 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
TP53 P04637 1/20 0.53
HSD11B1 P28845 1/20 0.52
SCD O00767 4/20 0.49
MAPT P10636 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
FPR2 P25090 3/20 0.48
PROKR1 Q8TCW9 3/20 0.48
RBP4 P02753 1/20 0.48
TTR P02766 1/20 0.48
HTR2C P28335 1/20 0.47
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3201810 0.84 HTR2C (0.63) MEN1KMT2AALDH1A1GAATP53
SCHEMBL3210439 0.84 MEN1 (0.57) MEN1KMT2AALDH1A1GAAMAPT
SCHEMBL3213292 0.83 MAPT (0.60) MEN1KMT2AALDH1A1GAAMAPT
SCHEMBL1471602 0.83 KMT2A (0.65) MEN1KMT2ASCDSMN1; SMN2LMNA
SCHEMBL3222003 0.83 HTR2C (0.62) MEN1KMT2AALDH1A1GAATP53
SCHEMBL3223665 0.82 MEN1 (0.55) MEN1KMT2AALDH1A1GAAMAPT
SCHEMBL1471495 0.82 TP53 (0.62) MEN1KMT2AGAACYP2C19TP53
SCHEMBL12828374 0.81 TP53 (0.48) MEN1KMT2ATP53SCDMAPT
SCHEMBL3212962 0.81 PTGDR (0.57) MEN1KMT2AALDH1A1GAATP53
SCHEMBL1471706 0.81 HSD11B1 (0.54) MEN1KMT2AALDH1A1TP53HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029648-A1 11-Beta HSD1 Inhibitors XIANG JASON SHAOYUN 2010-02-04 US disclosed
US-7632838-B2 11-beta HSD1 inhibitors WYETH (US) 2009-12-15 US disclosed
US-20070219198-A1 11-Beta HSD 1 inhibitors WYETH (US) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029648-A1 11-Beta HSD1 Inhibitors HSD11B1, HSD3B1, HSD11B2 MEN1 1354/4885KMT2A 1609/4885ALDH1A1 116/4885
US-20070219198-A1 11-Beta HSD 1 inhibitors HSD11B1, HSD11B2, HSD3B1 MEN1 1687/4885KMT2A 1591/4885ALDH1A1 123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.